OSR Holdings Files 8-K: Regulation FD & Financials
Ticker: OSRHW · Form: 8-K · Filed: Aug 6, 2025 · CIK: 1840425
| Field | Detail |
|---|---|
| Company | Osr Holdings, Inc. (OSRHW) |
| Form Type | 8-K |
| Filed Date | Aug 6, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: financial-statements, regulation-fd, corporate-update
Related Tickers: OSRH
TL;DR
OSR Holdings dropped an 8-K on Aug 6th - check the financials and Reg FD updates.
AI Summary
OSR Holdings, Inc. filed an 8-K on August 6, 2025, to report a Regulation FD Disclosure and Financial Statements and Exhibits. The company, formerly known as Bellevue Life Sciences Acquisition Corp., is incorporated in Delaware and operates in the Surgical & Medical Instruments & Apparatus industry.
Why It Matters
This filing provides crucial updates on regulatory disclosures and financial statements, offering insights into the company's current operational and financial standing.
Risk Assessment
Risk Level: low — This is a routine filing of financial statements and disclosures, not indicating any immediate material adverse events.
Key Numbers
- 0.0001 — Par Value Per Share (Common Stock Par Value)
- 11.50 — Exercise Price Per Share (Redeemable Warrants)
Key Players & Entities
- OSR Holdings, Inc. (company) — Registrant
- August 6, 2025 (date) — Date of Report
- Bellevue Life Sciences Acquisition Corp. (company) — Former Company Name
- Delaware (jurisdiction) — State of Incorporation
- 3841 (sic_code) — Standard Industrial Classification
FAQ
What specific information is being disclosed under Regulation FD?
The filing indicates a Regulation FD Disclosure, but the specific details of the disclosure are not provided in the provided text snippet.
What types of financial statements are included in this filing?
The filing states 'Financial Statements and Exhibits' are included, but the specific types of financial statements (e.g., balance sheet, income statement) are not detailed in the provided text.
When did OSR Holdings, Inc. change its name from Bellevue Life Sciences Acquisition Corp.?
The date of the name change was January 13, 2021.
What is the exercise price for the redeemable warrants?
The redeemable warrants are exercisable for shares of common stock at an exercise price of $11.50 per share.
What is the par value of OSR Holdings, Inc.'s common stock?
The par value of OSR Holdings, Inc.'s common stock is $0.0001 per share.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on August 6, 2025 regarding OSR Holdings, Inc. (OSRHW).